Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Microneedle-delivered polyglutamate effectively and safely improves hair growth in androgenetic alopecia.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

The combination therapy was effective and well-tolerated, especially in young patients.

Prostaglandin F2alpha and related compounds can increase hair growth and darken hair in mice.

Methylation of the 5-AR2 gene may cause resistance to Finasteride in BPH patients.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Melatonin may help with nerve pain, a hepatitis C drug is effective but has side effects, a treatment for mouth sores works but can cause blood issues, ear reconstruction with an implant is safe, HIV transmission from mother to child in Taiwan is now 0% with treatment, certain blood problems are more common in people with a tongue condition, a gene and being overweight are linked to hair loss in some women, a new technique could reduce radiation for lung nodule patients, a hepatitis treatment may lower cancer recurrence after a procedure, and adding extra screening improves tuberculosis detection in patients with lung infections.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.